Skip to main navigation Skip to search Skip to main content

Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation

  • Stefan O. Ciurea
  • , Barry Sadegi
  • , Andrew Wilbur
  • , Victoria Alagiozian-Angelova
  • , Sujata Gaitonde
  • , Lisa C. Dobogai
  • , Luke P. Akard
  • , Ronald Hoffman
  • , Damiano Rondelli

Research output: Contribution to journal › Article › peer-review

Abstract

Changes in spleen size postallogeneic haematopoietic stem cell transplantation (HSCT) in patients with primary myelofibrosis have been poorly characterized. We analysed 10 patients with myelofibrosis and splenomegaly following a reduced-intensity allogeneic HSCT. All patients fully engrafted donor cells including five patients with extensive splenomegaly. Extensive splenomegaly was associated with a prolonged time to neutrophil and platelet recovery. In all 10 patients, a progressive reduction of splenomegaly was documented within 12 months post-transplant and paralleled the reduction of marrow fibrosis. These findings suggest that myelofibrosis patients with extensive splenomegaly may proceed with allogeneic HSCT without prior splenectomy.

Original languageEnglish (US)
Pages (from-to)80-83
Number of pages4
JournalBritish Journal of Haematology
Volume141
Issue number1
DOIs
StatePublished - Apr 2008

Keywords

  • Myelofibrosis
  • Myeloproliferative disorder
  • Reduced-intensity conditioning stem cell transplantation
  • Splenomegaly

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation'. Together they form a unique fingerprint.

Cite this